Insulin-like growth factor-I (IGF-I) in COPD exacerbation

P. Kythreotis, P. Bakakos, N. Lolis, E. Ablianitis, A. Kokkini, D. Veldekis, A. Hadjiioannou, A. Rasidakis (Athens, Greece)

Source: Annual Congress 2002 - COPD - general -3
Session: COPD - general -3
Session type: Thematic Poster Session
Number: 1666
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Kythreotis, P. Bakakos, N. Lolis, E. Ablianitis, A. Kokkini, D. Veldekis, A. Hadjiioannou, A. Rasidakis (Athens, Greece). Insulin-like growth factor-I (IGF-I) in COPD exacerbation. Eur Respir J 2002; 20: Suppl. 38, 1666

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Autocrine expression of mechano and insulin-like 1 growth factors (MGF & IGF-1) in the diaphragm of severe COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 573s
Year: 2003

Serum levels of insulin-like growth factor binding protein-3 and vascular endothelial growth factor in obstructivesleep apnea patients. Effect of CPAP treatment
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012

Increased expression of insulin-like growth factor-binding protein-7 (IGFBP7) in fibroblasts from patients with emphysema
Source: Eur Respir J 2004; 24: Suppl. 48, 95s
Year: 2004

Endocrinological derangements in COPD
Source: Eur Respir J 2009; 34: 975-996
Year: 2009



Insulin-like growth factor binding protein-3 induction by transforming growth factor-β1 mediates differentiation of a myofibroblast phenotype in human lung fibroblasts
Source: Eur Respir J 2003; 22: Suppl. 45, 7s
Year: 2003

Fibroblast growth factor 23 (FGF23) and hypophosphatemia in patients with COPD
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011

Insulin-like growth factor I (IGF-I) and binding proteins (BP-2,3,4,6) expression during the progression of idiopathic fibrosing alveolitis (IFA) and sarcoidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 160s
Year: 2001

Influence of tobacco-smoking on serum level of transforming growth factor (TGF) beta 1 in COPD patients
Source: International Congress 2017 – COPD biomarkers
Year: 2017


Expression of basic fibroblast growth factor (bFGF) in smokers with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 454s
Year: 2004

Endocrinological disturbances in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 76S-80S
Year: 2003



Platelet-derived growth factor levels in sputum of patients with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 423s
Year: 2002

Stage-dependent regulation of brain-derived neurotrophic factor and transforming growth factor-β1 in patients with COPD
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012

Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression in NSCLC
Source: Eur Respir J 2005; 26: Suppl. 49, 459s
Year: 2005

Expression of transforming growth factor (TGF) in bronchial epithelium: association with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 92s
Year: 2001

Down regulation of human insulin-like growth factor in lung tissue of patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 574s
Year: 2007

Transforming growth factor-beta1 (TGF-beta1) gene polymorphism in chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 190s
Year: 2006

Transforming growth factor beta 1 (TGF-ß1) level as a marker of COPD severity
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020

Fibroblast growth factor 23 and Klotho contribute to airway inflammation
Source: Eur Respir J, 52 (1) 1800236; 10.1183/13993003.00236-2018
Year: 2018